Drug Approval Package
Zantac Efferdose (ranitidine hydrochloride)
Company: Glaxo Wellcome Research and Development.
Application No.: 020251, S06
Approval Date: 10/29/1999
-
Approval Letter(s) (PDF)
-
Clinical Pharmacology Biopharmaceutics Review(s) (PDF)
Part 1 (PDF)
Part 2 (PDF)